Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEN-PV: Ropeginterferon alfa-2b Self-administration in Polycythemia Vera
NCT02523638Phase 3Completed
- Sponsor
- AOP Health
- Start
- Jul 2015
- Primary completion
- Dec 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 8
01
Overview
A Phase 3 trial of ropeginterferon alfa-2b in polycythemia vera (PV), sponsored by AOP Health. Started Jul 2015; status: completed.
02
Drugs
ropeginterferon alfa-2b
03
Conditions
polycythemia vera (PV)
Beyond the preview
Go deeper on NCT02523638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02523638.